249 related articles for article (PubMed ID: 29263785)
1. Senescence and tumor suppression.
Hinds P; Pietruska J
F1000Res; 2017; 6():2121. PubMed ID: 29263785
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
3. To clear, or not to clear (senescent cells)? That is the question.
Lujambio A
Bioessays; 2016 Jul; 38 Suppl 1():S56-64. PubMed ID: 27417123
[TBL] [Abstract][Full Text] [Related]
4. The senescence-associated secretory phenotype: the dark side of tumor suppression.
Coppé JP; Desprez PY; Krtolica A; Campisi J
Annu Rev Pathol; 2010; 5():99-118. PubMed ID: 20078217
[TBL] [Abstract][Full Text] [Related]
5. Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.
Camorani S; Cerchia L; Fedele M; Erba E; D'Incalci M; Crescenzi E
Oncotarget; 2018 Apr; 9(28):19929-19944. PubMed ID: 29731994
[TBL] [Abstract][Full Text] [Related]
6. Senescent cells and their secretory phenotype as targets for cancer therapy.
Velarde MC; Demaria M; Campisi J
Interdiscip Top Gerontol; 2013; 38():17-27. PubMed ID: 23503512
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence: a double-edged sword in cancer therapy.
Xiao S; Qin D; Hou X; Tian L; Yu Y; Zhang R; Lyu H; Guo D; Chen XZ; Zhou C; Tang J
Front Oncol; 2023; 13():1189015. PubMed ID: 37771436
[TBL] [Abstract][Full Text] [Related]
8. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
9. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
[No Abstract] [Full Text] [Related]
10. Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing.
Mongiardi MP; Pellegrini M; Pallini R; Levi A; Falchetti ML
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513872
[TBL] [Abstract][Full Text] [Related]
11. SASP: Tumor Suppressor or Promoter? Yes!
Rao SG; Jackson JG
Trends Cancer; 2016 Nov; 2(11):676-687. PubMed ID: 28741506
[TBL] [Abstract][Full Text] [Related]
12. The Jekyll and Hyde of Cellular Senescence in Cancer.
Demirci D; Dayanc B; Mazi FA; Senturk S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
[TBL] [Abstract][Full Text] [Related]
13. The role of senescence in cancer development.
Mavrogonatou E; Pratsinis H; Kletsas D
Semin Cancer Biol; 2020 May; 62():182-191. PubMed ID: 31260734
[TBL] [Abstract][Full Text] [Related]
14. Biological functions of therapy-induced senescence in cancer.
Fitsiou E; Soto-Gamez A; Demaria M
Semin Cancer Biol; 2022 Jun; 81():5-13. PubMed ID: 33775830
[TBL] [Abstract][Full Text] [Related]
15. Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells.
Menicacci B; Laurenzana A; Chillà A; Margheri F; Peppicelli S; Tanganelli E; Fibbi G; Giovannelli L; Del Rosso M; Mocali A
J Gerontol A Biol Sci Med Sci; 2017 Sep; 72(9):1187-1195. PubMed ID: 28329136
[TBL] [Abstract][Full Text] [Related]
16. [The role of SASP in tumor microenvironment.].
Ohtani N
Clin Calcium; 2017; 27(6):835-843. PubMed ID: 28536322
[TBL] [Abstract][Full Text] [Related]
17. Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy.
Feng D; Wang J; Li D; Wu R; Wei W; Zhang C
Discov Oncol; 2023 Aug; 14(1):155. PubMed ID: 37624511
[TBL] [Abstract][Full Text] [Related]
18. Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu Q; Li B; Sun S; Sun S
Front Cell Dev Biol; 2020; 8():282. PubMed ID: 32411704
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent effects of cellular senescence in cancer development.
Lecot P; Alimirah F; Desprez PY; Campisi J; Wiley C
Br J Cancer; 2016 May; 114(11):1180-4. PubMed ID: 27140310
[TBL] [Abstract][Full Text] [Related]
20. [Involvement of phenotype secretor of senescent cells in the development of cancer, aging and the diseases associated with age].
González-Puertos VY; Maciel-Barón LÁ; Barajas-Gómez BA; López-Diazguerrero NE; Königsberg M
Gac Med Mex; 2015; 151(4):491-500. PubMed ID: 26290026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
